FrancophonIA/ELRC3.0 huggingface dataset:
English: Hyrimoz in combination with methotrexate is indicated for the treatment of active polyarticular juvenile idiopathic arthritis, in patients from the age of 2 years who have had an inadequate response to one or more disease-modifying anti-rheumatic drugs (DMARDs).
Croatian: Hyrimoz je, u kombinaciji s metotreksatom, indiciran za liječenje aktivnog poliartikularnog juvenilnog idiopatskog artritisa u bolesnika u dobi od 2 godine i starijih u kojih prethodnim liječenjem jednim ili više antireumatika koji modificiraju tijek bolesti (engl. disease-modifying anti-rheumatic drug,
English: If these medicines do not work well enough, patients will be given Hyrimoz to treat their polyarticular juvenile idiopathic arthritis or enthesitis-related arthritis.
Croatian: Ako ti lijekovi ne djeluju dovoljno dobro, u svrhu liječenja poliartikularnog juvenilnog idiopatskog artritisa ili artritisa povezanog s entezitisom bolesnicima će biti propisan lijek Hyrimoz.
English: Hyrimoz is contraindicated in moderate to severe heart failure (see section 4.3).
Croatian: Primjena lijeka Hyrimoz je kontraindicirana u bolesnika s umjerenim do teškim zatajenjem srca (vidjeti dio 4.3).
English: Hyrimoz 40 mg solution for injection in a single-use pre-filled syringe Hyrimoz is supplied in a single-use clear type I glass syringe with a rubber stopper and a stainless steel needle with an automatic needle guard with finger flange, rubber needle cap and plastic plunger, containing 0.8 ml solution.
Croatian: Hyrimoz 40 mg otopina za injekciju u napunjenoj štrcaljki za jednokratnu primjenu Hyrimoz se isporučuje u prozirnoj napunjenoj štrcaljki za jednokratnu primjenu (staklo tipa I), s gumenim čepom i iglom od nehrđajućeg čelika s automatskim štitnikom za iglu s hvatištem za prste, gumenim zatvaračem igle i plastičnim klipom, a koja sadrži 0,8 ml otopine.
English: Patients should be tested for HBV infection before initiating treatment with Hyrimoz.
Croatian: Bolesnike je potrebno prije početka terapije lijekom Hyrimoz testirati na HBV infekciju.
English: Children, adolescents and adults with polyarticular juvenile idiopathic arthritis Children, adolescents and adults from 2 years of age weighing 30 kg or more The recommended dose of Hyrimoz is 40 mg every other week.
Croatian: Djeca, adolescenti i odrasli s poliartikularnim juvenilnim idiopatskim artritisom Djeca, adolescenti i odrasli u dobi od 2 i više godina, tjelesne težine 30 kg ili više Preporučena doza lijeka Hyrimoz je 40 mg svaki drugi tjedan.
English: Keep this medicine out of the sight and reach of children.
Croatian: Kako čuvati lijek Hyrimoz Lijek čuvajte izvan pogleda i dohvata djece.
English: Hyrimoz is administered by subcutaneous injection.
Croatian: Hyrimoz se primjenjuje supkutanom injekcijom.
English: • Do not give Hyrimoz to children with polyarticular juvenile idiopathic arthritis below the age of
Croatian: • Nemojte davati Hyrimoz djeci s poliartikularnim juvenilnim idiopatskim artritisom mlađoj od 2 godine.
English: Hyrimoz is available as a pre-filled syringe and a pre-filled pen (SensoReady).
Croatian: Hyrimoz može biti dostupan u obliku napunjene štrcaljke i napunjene brizgalice (SensoReady).
English: • If you are about to have surgery or dental procedures tell your doctor that you are taking Hyrimoz.
Croatian: Kirurški ili stomatološki zahvati • Ako se spremate podvrgnuti kakvom kirurškom ili stomatološkom zahvatu, molimo da svog liječnika obavijestite o tome da primjenjujete lijek Hyrimoz.
English: Hyrimoz 40 mg solution for injection in single-use pre-filled SensoReady pen Hyrimoz is supplied in a single-use pre-filled syringe assembled into a triangular-shaped pen with transparent window and label (SensoReady).
Croatian: Hyrimoz 40 mg otopina za injekciju u napunjenoj SensoReady brizgalici za jednokratnu primjenu Hyrimoz se isporučuje u napunjenoj štrcaljki za jednokratnu primjenu uloženoj u brizgalicu trokutastog oblika s prozirnim prozorčićem i naljepnicom (SensoReady brizgalica).
English: Patients on Hyrimoz may receive concurrent vaccinations, except for live vaccines.
Croatian: Bolesnici koji primaju lijek Hyrimoz mogu istodobno primiti cjepiva, ali ne živa cjepiva.
English: Consequently, Hyrimoz can be used during breastfeeding..
Croatian: Stoga se Hyrimoz može primjenjivati tijekom dojenja.
English: • lichenoid skin reaction (itchy reddish-purple skin rash).
Croatian: • lihenoidne kožne reakcije (crvenkasto-ljubičasti kožni osip koji svrbi).
English: Antibiotics may be continued during treatment with Hyrimoz if necessary.
Croatian: Ako je potrebno, primjena antibiotika može se nastaviti i tijekom liječenja lijekom Hyrimoz.
English: Children, adolescents and adults with enthesitis-related arthritis Children, adolescents and adults from 6 years of age weighing 30 kg or more The recommended dose of Hyrimoz is 40 mg every other week.
Croatian: Djeca, adolescenti i odrasli s artritisom povezanim s entezitisom Djeca, adolescenti i odrasli u dobi od 6 i više godina, tjelesne težine 30 kg ili više Preporučena doza lijeka Hyrimoz je 40 mg svaki drugi tjedan.
English: • Hyrimoz pre-filled SensoReady pen/s (see Figure A).
Croatian: • Napunjena/e brizgalica/e SensoReady s lijekom Hyrimoz (vidjeti Sliku A).
English: Patients must therefore be monitored closely for infections, including tuberculosis, before, during and after treatment with Hyrimoz.
Croatian: Bolesnike se stoga mora pomno pratiti prije, za vrijeme i nakon završetka liječenja lijekom Hyrimoz zbog moguće pojave infekcija, uključujući tuberkulozu.
English: Hyrimoz is indicated for treatment of moderately to severely active ulcerative colitis in adult patients who have had an inadequate response to conventional therapy including corticosteroids and 6-mercaptopurine (6-MP) or azathioprine (AZA), or who are intolerant to or have medical contraindications for such therapies.
Croatian: Hyrimoz je indiciran za liječenje umjerenog do teškog oblika aktivnog ulceroznog kolitisa u odraslih bolesnika u kojih nije postignut zadovoljavajući odgovor na konvencionalno liječenje, uključujući kortikosteroide i 6-merkaptopurin (6-MP) ili azatioprin (AZA), ili koji ne podnose ili kod kojih postoje medicinske kontraindikacije za takve terapije.
English: Each syringe contains 40 mg/0.8 ml of Hyrimoz.
Croatian: Jedna brizgalica sadrži 40 mg/0,8 ml lijeka Hyrimoz.
English: If these medicines do not work well enough, you will be given Hyrimoz.
Croatian: Ako ti lijekovi ne djeluju dovoljno dobro, bit će Vam propisan lijek Hyrimoz.
English: Hyrimoz is indicated for the treatment of severe chronic plaque psoriasis in children and adolescents from 4 years of age who have had an inadequate response to or are inappropriate candidates for topical therapy and phototherapies.
Croatian: Plak psorijaza u djece Hyrimoz je indiciran za liječenje teške kronične plak psorijaze u djece i adolescenata u dobi od 4 ili više godina u kojih nije postignut zadovoljavajući odgovor ili koji nisu prikladni kandidati za topikalnu terapiju i fototerapije.
English: Treatment with Hyrimoz may result in the formation of autoimmune antibodies.
Croatian: Za vrijeme primjene lijeka Hyrimoz mogu se razviti autoimuna protutijela.
English: The recommended dose of Hyrimoz for patients with Crohn's disease from 6 to 17 years of age is based on body weight (table 4).
Croatian: Preporučena doza lijeka Hyrimoz za bolesnike s Crohnovom bolešću u dobi od 6 do 17 godina određuje se na temelju tjelesne težine (tablica 4).
English: Hyrimoz is indicated for the treatment of active enthesitis-related arthritis in patients, 6 years of age and older, who have had an inadequate response to, or who are intolerant of, conventional therapy (see section 5.1).
Croatian: Artritis povezan s entezitisom Hyrimoz je indiciran za liječenje aktivnog artritisa povezanog s entezitisom u bolesnika u dobi od 6 godina i starijih u kojih nije postignut zadovoljavajući odgovor ili koji ne podnose konvencionalnu terapiju (vidjeti dio 5.1).
English: Hyrimoz is indicated for the treatment of moderately to severely active Crohn's disease in paediatric patients (from 6 years of age) who have had an inadequate response to conventional therapy including primary nutrition therapy and a corticosteroid and / or an immunomodulator, or who are intolerant to or have contraindications for such therapies.
Croatian: Hyrimoz je indiciran za liječenje umjerenog do teškog oblika aktivne Crohnove bolesti u pedijatrijskih bolesnika (u dobi od 6 godina i starijih) u kojih nije postignut zadovoljavajući odgovor na konvencionalnu terapiju, uključujući primarnu nutritivnu terapiju i liječenje kortikosteroidom i/ili imunomodulatorom ili u onih koji ne podnose ili u kojih su takve vrste terapija kontraindicirane.
English: Hyrimoz can be taken together with methotrexate or certain disease-modifying anti-rheumatic agents (sulfasalazine, hydroxychloroquine, leflunomide and injectable gold preparations), corticosteroids or pain medications including non-steroidal anti-inflammatory drugs (NSAIDs).
Croatian: Hyrimoz se može primjenjivati istodobno s metotreksatom ili nekim antireumaticima koji mijenjaju tijek bolesti (sulfasalazinom, hidroksiklorokinom, leflunomidom i injekcijskim pripravcima zlata),
English: A patient who requires surgery while on Hyrimoz should be closely monitored for infections, and appropriate actions should be taken.
Croatian: Bolesnike kojima je za vrijeme liječenja lijekom Hyrimoz potreban operativni zahvat potrebno je pomno pratiti zbog moguće pojave infekcija i poduzeti odgovarajuće mjere.
English: EU/1/18/1286/003 6 pre-filled syringes (3 packs of 2)
Croatian: EU/1/18/1286/003 6 napunjenih štrcaljki (3 pakiranja po 2)
English: EU/1/18/1286/004 1 pre-filled pen EU/1/18/1286/005 2 pre-filled pens
Croatian: EU/1/18/1286/004 1 napunjena brizgalica EU/1/18/1286/005 2 napunjene brizgalice
English: There is little experience from re-administration after more than 8 weeks since the previous dose.
Croatian: Postoji malo podataka o ponovnoj primjeni lijeka Hyrimoz kad je prekid terapije trajao duže od 8 tjedana.
English: Cartons contain 1 and 2 pre-filled syringes of Hyrimoz.
Croatian: Kutije sadrže 1 ili 2 napunjene štrcaljke lijeka Hyrimoz.
English: The recommended Hyrimoz dose for patients with plaque psoriasis from 4 to 17 years of age is based on body weight (table 3).
Croatian: Preporučena doza lijeka Hyrimoz za bolesnike s plak psorijazom u dobi od 4 do 17 godina određuje se na temelju tjelesne težine (tablica 3).
English: Hyrimoz is indicated for the treatment of adults with severe active ankylosing spondylitis who have had an inadequate response to conventional therapy.
Croatian: Hyrimoz je indiciran za liječenje teškog oblika aktivnog ankilozantnog spondilitisa u odraslih osoba u kojih nije postignut zadovoljavajući odgovor na konvencionalno liječenje.
English: EU/1/18/1286/001 1 pre-filled syringe EU/1/18/1286/002 2 pre-filled syringes
Croatian: EU/1/18/1286/001 1 napunjena štrcaljka EU/1/18/1286/002 2 napunjene štrcaljke
English: • When needed (for example when you are travelling), Hyrimoz may be stored at room temperature (up to 25°C) for a maximum period of 14 days - be sure to protect it from light.
Croatian: • Kad je to potrebno (na primjer kad putujete), Hyrimoz se može čuvati na sobnoj temperaturi (do
English: Hyrimoz is injected under the skin (subcutaneous use).
Croatian: Hyrimoz se ubrizgava pod kožu (supkutana primjena).
English: Hyrimoz is used to treat rheumatoid arthritis in adults.
Croatian: Hyrimoz je namijenjen liječenju reumatoidnog artritisa u odraslih.
English: Hyrimoz 40 mg / 0.8 ml injection adalimumab
Croatian: Hyrimoz 40 mg / 0,8 ml injekcija adalimumab
English: Multipack cartons contain 6 (3 packs of 2) pre-filled syringes of Hyrimoz.
Croatian: Višestruka pakiranja sadrže 6 (3 pakiranja po 2) napunjenih štrcaljki lijeka Hyrimoz.
English: Hyrimoz is only available as 40 mg pre-filled syringe and 40 mg pre-filled pen.
Croatian: Hyrimoz je dostupan samo kao napunjena štrcaljka od 40 mg i napunjena brizgalica od 40 mg.
English: Hyrimoz is administered by injection under the skin (by subcutaneous injection).
Croatian: Hyrimoz se primjenjuje injekcijom pod kožu (supkutanom injekcijom).
English: Be sure that you read, understand, and follow these Instructions for Use before injecting Hyrimoz.
Croatian: Prije ubrizgavanja lijeka Hyrimoz morate pročitati, razumjeti i pridržavati se ovih Uputa za uporabu.
English: EU/1/18/1286/006 6 pre-filled pens (3 packs of 2)
Croatian: EU/1/18/1286/006 6 napunjenih brizgalica (3 pakiranja po 2)
English: All patients, and in particular patients with a medical history of extensive immunosuppressant therapy or psoriasis patients with a history of PUVA treatment should be examined for the presence of nonmelanoma skin cancer prior to and during treatment with Hyrimoz.
Croatian: Sve bolesnike, a posebno one koji u anamnezi imaju dugotrajno korištenje imunosupresivne terapije ili bolesnike s psorijazom i PUVA liječenjem u anamnezi, potrebno je prije i za vrijeme liječenja lijekom
English: In non-infectious uveitis, corticosteroids or other medicines that influence the immune system may be continued while using Hyrimoz.
Croatian: Kod nezaraznog uveitisa se uz lijek Hyrimoz mogu nastaviti primjenjivati kortikosteroidi ili drugi lijekovi koji utječu na imunološki sustav.
English: Your Hyrimoz single-use pre-filled SensoReady pen
Croatian: Vaša jednokratna napunjena brizgalica SensoReady s lijekom Hyrimoz
English: Hyrimoz is indicated for the treatment of paediatric chronic non-infectious anterior uveitis in patients from 2 years of age who have had an inadequate response to or are intolerant to conventional therapy, or in whom conventional therapy is inappropriate.
Croatian: Hyrimoz je indiciran za liječenje kroničnog neinfektivnog anteriornog uveitisa u djece u dobi od 2 godine i starije u koje nije postignut zadovoljavajući odgovor na konvencionalno liječenje, koji ne podnose konvencionalno liječenje ili u kojih konvencionalno liječenje nije prikladno.
English: Glucocorticoids, salicylates, nonsteroidal anti-inflammatory drugs, or analgesics can be continued during treatment with Hyrimoz.
Croatian: Za vrijeme liječenja lijekom Hyrimoz može se nastaviti s davanjem glukokortikoida, salicilata, nesteroidnih protuupalnih lijekova ili analgetika.
English: Hyrimoz 40 mg solution for injection in pre-filled syringe Hyrimoz 40 mg solution for injection in pre-filled pen
Croatian: Hyrimoz 40 mg otopina za injekciju u napunjenoj štrcaljki Hyrimoz 40 mg otopina za injekciju u napunjenoj brizgalici
English: The recommended dose of Hyrimoz for patients with ankylosing spondylitis, axial spondyloarthritis without radiographic evidence of AS and for patients with psoriatic arthritis is 40 mg adalimumab administered every other week as a single dose via subcutaneous injection.
Croatian: aksijalnog spondiloartritisa bez radiografskog dokaza ankilozantnog spondilitisa te u bolesnika sa psorijatičnim artritisom iznosi 40 mg adalimumaba, a primjenjuje se kao pojedinačna doza svaka dva tjedna.
English: Hyrimoz dose for paediatric patients with plaque psoriasis Patient weight
Croatian: Tablica 3. Doza lijeka Hyrimoz za pedijatrijske bolesnike s plak psorijazom
English: The recommended dose of Hyrimoz for patients with enthesitis-related arthritis from 6 years of age is based on body weight (table 2).
Croatian: Preporučena doza lijeka Hyrimoz za bolesnike s artritisom povezanim s entezitisom u dobi od 6 i više godina određuje se na temelju tjelesne težine (tablica 2).
English: Thus, it is not possible to use Hyrimoz for children who require less than a full 40 mg dose.
Croatian: Zato se Hyrimoz ne može koristiti u djece koja zahtijevaju manje od cijele doze od 40 mg.
English: How to use Hyrimoz
Croatian: Kako primjenjivati lijek Hyrimoz
English: Hyrimoz is used to treat ulcerative colitis in adults.
Croatian: Hyrimoz je namijenjen liječenju ulceroznog kolitisa u odraslih.
English: Hyrimoz dose for patients with enthesitis-related arthritis Patient weight
Croatian: Tablica 2. Doza lijeka Hyrimoz za bolesnike s artritisom povezanim s entezitisom
English: There is no relevant use of Hyrimoz in children aged less than 2 years in this indication.
Croatian: Nema relevantne primjene lijeka Hyrimoz u djece mlađe od 2 godine u ovoj indikaciji.
English: Package leaflet: Information for the patient Hyrimoz 40 mg solution for injection in pre-filled pen adalimumab
Croatian: Uputa o lijeku: Informacije za bolesnika Hyrimoz 40 mg otopina za injekciju u napunjenoj brizgalici adalimumab
English: Hyrimoz is indicated for treatment of moderately to severely active Crohn's disease in adult patients who have not responded despite a full and adequate course of therapy with a corticosteroid and / or an immunosuppressant; or who are intolerant to or have medical contraindications for such therapies.
Croatian: Hyrimoz je indiciran za liječenje umjerenog do teškog oblika aktivne Crohnove bolesti u odraslih bolesnika u kojih unatoč prethodnom potpunom i odgovarajućem tijeku liječenja kortikosteroidima i/ili imunosupresivima nije postignut odgovor ili kod bolesnika koji ih ne podnose ili im je takva terapija kontraindicirana.
English: Hyrimoz 40 mg solution for injection (injection) in pre-filled syringe is supplied as a 0.8 ml clear to slightly opalescent, colourless to slightly yellowish solution.
Croatian: Hyrimoz 40 mg otopina za injekciju (injekcija) u napunjenoj brizgalici isporučuje se kao 0,8 ml bistre do blago opalescentne, bezbojne do blago žućkaste otopine.
English: In adolescent patients with inadequate response to Hyrimoz 40 mg every other week, an increase in dosage to 40 mg every week or 80 mg every other week may be considered.
Croatian: U adolescentnih bolesnika u kojih nije postignut zadovoljavajući odgovor na lijek Hyrimoz u dozi od 40 mg svaki drugi tjedan može se razmotriti povećanje doziranja na 40 mg svaki tjedan ili 80 mg svaki drugi tjedan.
English: Thus, it is not possible to administer Hyrimoz to paediatric patients that require less than a full 40 mg dose.
Croatian: Zato se Hyrimoz ne može primijeniti u pedijatrijskih bolesnika koji zahtijevaju manje od cijele doze od 40 mg.
English: Multipack cartons contain 6 (3 packs of 2) pre-filled pens of Hyrimoz.
Croatian: Višestruka pakiranja sadrže 6 (3 pakiranja po 2) napunjenih brizgalica lijeka Hyrimoz.
English: Hyrimoz is used to treat psoriatic arthritis in adults.
Croatian: Hyrimoz je namijenjena liječenju psorijatičnog artritisa u odraslih.
English: Hyrimoz can also be used to treat severe, active and progressive rheumatoid arthritis without previous methotrexate treatment.
Croatian: U svrhu liječenja teškog, aktivnog i progresivnog reumatoidnog artritisa, Hyrimoz se može primijeniti i bez prethodnog liječenja metotreksatom.
English: The recommended dose of Hyrimoz for adult patients with rheumatoid arthritis is 40 mg adalimumab administered every other week as a single dose via subcutaneous injection.
Croatian: U odraslih bolesnika s reumatoidnim artritisom preporučena doza lijeka Hyrimoz iznosi 40 mg, a daje se kao jednokratna doza svaka dva tjedna supkutanom injekcijom.
English: Hyrimoz should be used with caution in patients with mild heart failure (NYHA class I/II).
Croatian: . Zato se bolesnicima s blagim zatajenjem srca (NYHA razred I/II) Hyrimoz mora davati oprezno.
English: paleness.
Croatian: Hyrimoz.
English: Hyrimoz 40 mg / 0.8 ml injection adalimumab SC
Croatian: Hyrimoz 40 mg / 0,8 ml injekcija adalimumab s.c.
English: The recommended Hyrimoz dose is 80 mg at week 0 followed by 40 mg every other week starting at week 1 via subcutaneous injection.
Croatian: Preporučena doza lijeka Hyrimoz je 80 mg u nultom tjednu, nakon koje se primjenjuje doza od 40 mg svaki drugi tjedan, počevši od prvog tjedna, supkutanom injekcijom.
English: Hyrimoz 40 mg solution for injection in pre-filled syringe adalimumab
Croatian: Hyrimoz 40 mg otopina za injekciju u napunjenoj štrcaljki adalimumab
English: Hyrimoz 40 mg injection adalimumab
Croatian: Hyrimoz 40 mg injekcija adalimumab s.c.
English: Hyrimoz is used to treat moderate to severe plaque psoriasis in adults.
Croatian: Hyrimoz je namijenjena liječenju umjerene do teške plak psorijaze u odraslih.
English: Hyrimoz is only available as 40 mg pre-filled syringe / pre-filled pen.
Croatian: Hyrimoz je dostupan samo kao napunjena štrcaljka od 40 mg/napunjena brizgalica od 40 mg.
English: Hyrimoz is used in adults to treat these conditions.
Croatian: Hyrimoz je namijenjen liječenju takvih zdravstvenih stanja u odraslih.
English: If you take Hyrimoz the risk of getting lymphoma, leukaemia, or other cancers may increase.
Croatian: Rizik obolijevanja od limfoma, leukemije ili drugih tumora može se povećati ako primjenjujete lijek Hyrimoz.
English: You should record the date when your pre-filled syringe is first removed from the refrigerator, and the date after which it should be discarded.
Croatian: Trebate zabilježiti datum kada ste napunjenu štrcaljku prvi put izvadili iz hladnjaka i datum nakon kojeg je trebate baciti.
English: Hyrimoz 40 mg solution for injection in pre-filled syringe:
Croatian: Hyrimoz 40 mg otopina za injekciju u napunjenoj štrcaljki:
English: Patients should be instructed to seek medical advice if signs / symptoms suggestive of a tuberculosis infection (e.g., persistent cough, wasting/weight loss, low grade fever, listlessness) occur during or after therapy with Hyrimoz.
Croatian: Bolesnike se mora upozoriti da se obrate liječniku ako se za vrijeme ili nakon liječenja lijekom Hyrimoz pojave znakovi/simptomi koji upućuju na tuberkuloznu infekciju (npr. perzistirajući kašalj,
English: The recommended dose of Hyrimoz for paediatric patients with uveitis from 2 years of age is based on body weight (table 5).
Croatian: Preporučena doza lijeka Hyrimoz za pedijatrijske bolesnike s uveitisom u dobi od 2 i više godina određuje se na temelju tjelesne težine (tablica 5).
English: Room spinning sensation (vertigo) and vision disturbances may occur after taking Hyrimoz.
Croatian: Nakon uzimanja lijeka Hyrimoz može se javiti osjećaj da se prostorija vrti (vrtoglavica) te smetnje vida.
English: The adjusted OR (accounting for baseline differences) was 1.10 (95% CI 0.452.73) with RA and CD combined.
Croatian: Prilagođen OR (kod kojega su uzete u obzir početne razlike) iznosio je 1,10 (95% CI:
English: The recommended dose of Hyrimoz is an initial dose of 80 mg (as two 40 mg injections in one day), followed by 40 mg every other week starting one week later.
Croatian: Preporučeno doziranje lijeka Hyrimoz je početna doza od 80 mg (u obliku dvije injekcije od 40 mg u jednom danu), a zatim 40 mg svaka dva tjedna, počevši tjedan dana kasnije.
English: Thus, it is not possible to administer Hyrimoz to patients that require less than a full 40 mg dose.
Croatian: Zato se Hyrimoz ne može primijeniti u bolesnika koji zahtijevaju manje od cijele doze od 40 mg.
English: Some patients who experience decrease in their response to Hyrimoz 40 mg every other week may benefit from an increase in dosage to 40 mg Hyrimoz every week or 80 mg every other week.
Croatian: U nekih bolesnika u kojih dođe do slabljenja odgovora na terapiju Hyrimozom u dozi od 40 mg svaki drugi tjedan možda će biti korisno povećati doziranje na 40 mg lijeka Hyrimoz svaki tjedan ili 80 mg svaki drugi tjedan.
English: The recommended Hyrimoz induction dose regimen for adult patients with moderate to severe ulcerative colitis is 160 mg at week 0 (given as four 40 mg injections in one day or as two 40 mg injections per day for two consecutive days) and 80 mg at week 2 (given as two 40 mg injections in one day).
Croatian: Preporučena indukcijska doza lijeka Hyrimoz u odraslih bolesnika s umjerenim do teškim ulceroznim kolitisom je 160 mg u nultom tjednu (primijenjena u obliku četiri injekcije od 40 mg u jednom danu ili kao dvije injekcije od 40 mg na dan kroz dva uzastopna dana) i 80 mg u drugom tjednu (primijenjena u obliku dvije injekcije od 40 mg u jednom danu).
English: • You might get infections more easily while you are receiving Hyrimoz treatment.
Croatian: • Dok primate terapiju lijeka Hyrimoz, možete biti podložniji infekcijama.